Applied Therapeutics Stock In The News
| APLT Stock | USD 4.46 0.05 1.13% |
The tone or emotional content of news articles related to Applied Therapeutics can affect its prices. Positive news sentiment can lead to an increase in demand for Applied Therapeutics' stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Applied Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Applied Therapeutics. The specific impact of Applied Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Applied Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Applied Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Applied Therapeutics Backtesting and Applied Therapeutics Hype Analysis. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.
Applied |
Applied Therapeutics Today Top News and Investor Outlook
Applied Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Applied and other traded companies coverage. We help investors stay connected with Applied headlines for the 24th of April to make an informed investment decision based on correlating the impacts of news items on Applied Stock performance. Please note that trading solely based on the Applied Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.Applied Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Applied earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Applied Therapeutics that are available to investors today. That information is available publicly through Applied media outlets and privately through word of mouth or via Applied internal channels. However, regardless of the origin, that massive amount of Applied data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Applied Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Applied Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Applied Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Applied Therapeutics alpha.
Applied Largest EPS Surprises
Earnings surprises can significantly impact Applied Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-09 | 2022-09-30 | -0.48 | -0.4 | 0.08 | 16 | ||
2024-03-06 | 2023-12-31 | -0.23 | -0.34 | -0.11 | 47 | ||
2023-08-10 | 2023-06-30 | -0.26 | -0.37 | -0.11 | 42 | ||
2019-08-12 | 2019-06-30 | -0.49 | -0.6 | -0.11 | 22 | ||
2023-05-11 | 2023-03-31 | -0.31 | -0.18 | 0.13 | 41 | ||
2021-08-12 | 2021-06-30 | -1.13 | -0.99 | 0.14 | 12 |
Applied Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Applied Therapeutics Stock. Current markets are strongly bullish. About 83% of major world exchanges and indexes are currently up. See today's market update for more information.
16th of April 2024
Applied Therapeutics Trading 4.2 percent Higher - MarketBeat at news.google.com
12th of April 2024
Insider Trading at MacroaxisInsider
4th of April 2024
Applied Therapeutics reveals Phase 3 data on heart drug at investing.com
28th of March 2024
FDA extends review of Applied Therapeutics Galactosemia drug at investing.com
22nd of March 2024
Applied Therapeutics files to sell 14.29M common shares for holders at seekingalpha.com
18th of March 2024
Applied therapeutics CFO sells shares worth over 150k at investing.com
11th of March 2024
Applied Therapeutics Shares Gap Down to 6.93 at thelincolnianonline.com
8th of March 2024
Applied Therapeutics Inc Announces Year-End 2023 Financial Results and Clinical Progress at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Applied Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Applied Therapeutics' short interest history, or implied volatility extrapolated from Applied Therapeutics options trading.
Check out Applied Therapeutics Backtesting and Applied Therapeutics Hype Analysis. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Applied Stock analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Applied Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied Therapeutics. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.42) | Revenue Per Share 0.119 | Return On Assets (0.87) | Return On Equity (6.82) |
The market value of Applied Therapeutics is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Applied Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied Therapeutics' market value can be influenced by many factors that don't directly affect Applied Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.